RxDoctor Payments Data

Erik Walker, MD

Family Medicine · Oviedo, FLNPI 1710977954

Payments from drug & device makers

$9,959in general payments, 2019–2025

Across 568 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$1K
  • Novo Nordisk$882
  • Biohaven Pharmaceuticals, Inc.$704
  • Johnson & Johnson$694
  • Boehringer Ingelheim$501
  • plus $5K from 45 others

What the payments were for

  • Food & beverage$9,948100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,959 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$7,381
Medicare patients
48
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban52$47,213
OzempicSemaglutide21$21,753
JardianceEmpagliflozin15$21,321
FarxigaDapagliflozin Propanediol24$21,204
XareltoRivaroxaban12$18,729
TrulicityDulaglutide13$12,410
SymbicortBudesonide/Formoterol Fumarate14$4,079
Atorvastatin Calcium260$2,195
Levothyroxine Sodium234$2,192
Lisinopril224$1,289
Losartan Potassium116$1,131
Metoprolol Succinate79$1,129
Tamsulosin Hcl65$1,069
Amlodipine Besylate212$1,055
Omeprazole70$993

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$390$47,21352 claims
AstraZenecaFarxiga, Symbicort$429$25,28338 claims
Novo NordiskOzempic$882$21,75321 claims
Boehringer IngelheimJardiance$501$21,32115 claims
Johnson & JohnsonXarelto$694$18,72912 claims
Lilly USA, LLCTrulicity$431$12,41013 claims
AbbVieSynthroid$1,203$96714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Oviedo

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →